These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 9837827)
1. A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. Canzian F; Amati P; Harach HR; Kraimps JL; Lesueur F; Barbier J; Levillain P; Romeo G; Bonneau D Am J Hum Genet; 1998 Dec; 63(6):1743-8. PubMed ID: 9837827 [TBL] [Abstract][Full Text] [Related]
2. Mapping of a gene predisposing to familial thyroid tumors with cell oxyphilia to chromosome 19 and exclusion of JUN B as a candidate gene. Kraimps JL; Canzian F; Jost C; Menet E; Amati P; Levillian P; Harach R; Lesueur F; Barbier J; Romeo G; Bonneau D Surgery; 1999 Dec; 126(6):1188-94. PubMed ID: 10598206 [TBL] [Abstract][Full Text] [Related]
3. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. McKay JD; Thompson D; Lesueur F; Stankov K; Pastore A; Watfah C; Strolz S; Riccabona G; Moncayo R; Romeo G; Goldgar DE J Med Genet; 2004 Jun; 41(6):407-12. PubMed ID: 15173224 [TBL] [Abstract][Full Text] [Related]
4. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci. Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407 [TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity in familial nonmedullary thyroid carcinoma: exclusion of linkage to RET, MNG1, and TCO in 56 families. NMTC Consortium. Lesueur F; Stark M; Tocco T; Ayadi H; Delisle MJ; Goldgar DE; Schlumberger M; Romeo G; Canzian F J Clin Endocrinol Metab; 1999 Jun; 84(6):2157-62. PubMed ID: 10372725 [TBL] [Abstract][Full Text] [Related]
6. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations. Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288 [TBL] [Abstract][Full Text] [Related]
7. Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas. Bonora E; Evangelisti C; Bonichon F; Tallini G; Romeo G Br J Cancer; 2006 Dec; 95(11):1529-36. PubMed ID: 17088905 [TBL] [Abstract][Full Text] [Related]
8. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444 [TBL] [Abstract][Full Text] [Related]
9. Mapping a new familial thyroid epithelial neoplasia susceptibility locus to chromosome 8p23.1-p22 by high-density single-nucleotide polymorphism genome-wide linkage analysis. Cavaco BM; Batista PF; Sobrinho LG; Leite V J Clin Endocrinol Metab; 2008 Nov; 93(11):4426-30. PubMed ID: 18765515 [TBL] [Abstract][Full Text] [Related]
10. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma. Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282 [TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at 19p13.2 and 2q21 in tumours from familial clusters of non-medullary thyroid carcinoma. Prazeres HJ; Rodrigues F; Soares P; Naidenov P; Figueiredo P; Campos B; Lacerda M; Martins TC Fam Cancer; 2008; 7(2):141-9. PubMed ID: 17823852 [TBL] [Abstract][Full Text] [Related]
12. An update on familial nonmedullary thyroid cancer. Ammar SA; Alobuia WM; Kebebew E Endocrine; 2020 Jun; 68(3):502-507. PubMed ID: 32162184 [TBL] [Abstract][Full Text] [Related]
13. Allelic loss on chromosomes 2q21 and 19p 13.2 in oxyphilic thyroid tumors. Stankov K; Pastore A; Toschi L; McKay J; Lesueur F; Kraimps JL; Bonneau D; Gibelin H; Levillain P; Volante M; Papotti M; Romeo G Int J Cancer; 2004 Sep; 111(3):463-7. PubMed ID: 15221978 [TBL] [Abstract][Full Text] [Related]
14. The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Park YJ; Ahn HY; Choi HS; Kim KW; Park DJ; Cho BY Thyroid; 2012 Apr; 22(4):356-62. PubMed ID: 22280228 [TBL] [Abstract][Full Text] [Related]
15. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Mazeh H; Benavidez J; Poehls JL; Youngwirth L; Chen H; Sippel RS Thyroid; 2012 Jan; 22(1):3-8. PubMed ID: 22136209 [TBL] [Abstract][Full Text] [Related]